Anti-inflammatory action of a phosphatidylcholine, phosphatidylethanolamine and N-acylphosphatidylethanolamine-enriched diet in carrageenan-induced pleurisy

European Surgical Research

Volumn 42, Issue 1, 2008, Pages 40-48

  Eros G ^a   Varga, G ^a   Varadi R ^a   Czobel M ^a   Kaszaki, J ^a   Ghyczy, M ^b   Boros, M ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b NONE

Author keywords

Inflammation; Leukocyte; Mast cell; Nitric oxide synthase; Phospholipids; Xanthine oxidase

Indexed keywords

ACETYLSALICYLIC ACID; CARRAGEENAN; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; N ACYLPHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MECHANISM; INFLAMMATION; LEUKOCYTE; LEUKOCYTE MIGRATION; LUNG ALVEOLUS CELL; LUNG BIOPSY; LUNG INFILTRATE; LUNG PARENCHYMA; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PLEURISY; PRIORITY JOURNAL; STAINING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CELL DEGRANULATION; DIETARY SUPPLEMENTS; INFLAMMATION; LECITHINS; LEUKOCYTES; LUNG; MALE; MAST CELLS; MICE; NITRIC OXIDE SYNTHASE TYPE II; PEROXIDASE; PHOSPHATIDYLETHANOLAMINES; PLEURISY; XANTHINE DEHYDROGENASE;

EID: 55149095177     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167856     Document Type: Article

References (60)

1. Rainsford KD: Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007;42:3-27.
2. Dunjic BS, Axelson J: Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats. Scand J Gastroenterol 1993;28:89-94.
3. Barrios JM, Lichtenberger LM: Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats. Gastroenterology 2000;118:1179-1186.
4. Ghyczy M, Boros M: Electrophilic methyl groups present in the diet ameliorate pathological states induced by reductive and oxidative stress: a hypothesis. Br J Nutr 2001;85:409-414.
5. Kent C: Eukaryotic phospholipid biosynthesis. Annu Rev Biochem 1995;64:315-343.
6. Vance JE, Vance DE: Phospholipid biosynthesis in mammalian cells. Biochem Cell Biol 2004;82:113-128.
7. Okamoto Y, Wang J, Morishita J, Ueda N: Biosynthetic pathways of the endocannabinoid anandamide. Chem Biodivers 2007;4:1842-1857.
8. Schmid HH, Schmid PC, Berdyshev EV: Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. Chem Phys Lipids 2002;121:111-134.
9. Schmid HH, Schmid PC, Natarajan V: The N-acylation-phosphodiesterase pathway and cell signaling. Chem Phys Lipids 1996;80:133-142.
10. Lieber CS, Leo MA: Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol Clin Exp Res 1997;21:375-379.
11. Eros G, Kaszaki J, Czobel M, Boros M: Systemic phosphatidylcholine pretreatment protects canine esophageal mucosa during acute experimental biliary reflux. World J Gastroenterol 2006;12:271-279.
12. Gera L, Varga R, Török L, Kaszaki J, Szabó A, Nagy K, Boros M: Beneficial effects of phosphatidylcholine during hindlimb reperfusion. J Surg Res 2007;139:45-50.
13. Ghyczy M, Torday C, Kaszaki J, SzabóA, Czóbel M, Boros M: Hypoxia-induced generation of methane in mitochondria and eukaryotic cells: an alternative approach to methanogenesis. Cell Physiol Biochem 2008;21:251-258.
14. Ackerman N, Tomolonis A, Miram L, Kheifets J, Martinez S, Carter A: Three day pleural inflammation: a new model to detect drug effects on macrophage accumulation. J Pharmacol Exp Ther 1980;215:588-595.
15. Ghiara P, Bartalini M, Tagliabue A, Boraschi D: Anti-inflammatory effect of IFN-beta in carrageenan-induced pleurisy in the mouse. Clin Exp Immunol 1986;66:606-614.
16. Tomlinson A, Appleton I, Moore AR, Gilroy DW, Willis D, Mitchell JA, Willoughby DA: Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy. Br J Pharmacol 1994;113:693-698.
17. Moore AR: Pleural models of inflammation: immune and nonimmune. Methods Mol Biol 2003;225:123-128.
18. Day SM, Lockhart JC, Ferrell WR, McLean JS: Divergent roles of nitrergic and prostanoid pathways in chronic joint inflammation. Ann Rheum Dis 2004;63:1564-1570.
19. Ialenti A, Ianaro A, Moncada S, Di Rosa M: Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992;211:177-182.
20. Kuebler WM, Abels C, Schuerer L, Goetz AE: Measurement of neutrophil content in brain and lung tissue by a modified myeloperoxidase assay. Int J Microcirc Clin Exp 1996;16:89-97.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
22. Szabo C, Mitchell JA, Thiemermann C, Vane JR: Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993;108:786-792.
23. Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA: A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med 1989;6:607-615.
24. Fortun PJ, Hawkey CJ: Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 2007;23:134-141.
25. Oh-ishi S, Hayashi I, Hayashi M, Yamaki K, Utsunomiya I: Pharmacological demonstration of inflammatory mediators using experimental inflammatory models: rat pleurisy induced by carrageenan and phorbol myristate acetate. Dermatologica 1989;179(suppl 1):68-71.
26. Cuzzocrea S, Mazzon E, Calabro G, Dugo L, De Sarro A, van De Loo FA, Caputi AP: Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med 2000;162:1859-1866.
27. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S: Mechanisms of peroxynitrite-induced injury to pulmonary surfactant. Am J Physiol 1993;265:L555-L564.
28. Friedl R, Pichler I, Spieckermann P, Moeslinger T: Oxidized phosphatidylcholine but not native phosphatidylcholine inhibits inducible nitric oxide synthase in RAW 264.7 macrophages. Life Sci 2006;78:1586-1591.
29. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA: Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994;269:26066-26075.
30. Kuehl FA, Jacob TA, Ganley OH, Ormond RE, Meisinger MAP: The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J Am Chem Soc 1957;79:5577-5578.
31. Natarajan V, Reddy PV, Schmid PC, Schmid HHO: On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart. Biochim Biophys Acta 1981;664:445-448.
32. Natarajan V, Reddy PV, Schmid PC, Schmid HHO: N-Acylation of ethanolamine phospholipids in canine myocardium. Biochim Biophys Acta 1982;712:342-355.
33. Cleland LG, Shandling M, Percy JS, Poznansky MJ: Liposomes: a new approach to gold therapy? J Rheumatol 1979;S5:154-163.
34. Blusztajn JK, Wurtman RJ: Choline and cholinergic neurons. Science 1983;221:614-620.
35. Ulus IH, Wurtman RJ, Mauron C, Blusztajn JK: Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res 1989;484:217-227.
36. Lee HC, Fellenz-Maloney MP, Liscovitch M, Blusztajn JK: Phospholipase D-catalyzed hydrolysis of phosphatidylcholine provides the choline precursor for acetylcholine synthesis in a human neuronal cell line. Proc Natl Acad Sci USA 1993;90:10086-10090.
37. Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007;117:289-296.
38. Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, Vogel P, Rothe G, Schmitz G: Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 2003;44:754-761.
39. Yan JJ, Jung JS, Lee JE, Lee J, Huh SO, Kim HS, Jung KC, Cho JY, Nam JS, Suh HW, Kim YH, Song DK: Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 2004;10:161-167.
40. Ilcol YO, Yilmaz Z, Ulus IH: Endotoxin alters serum-free choline and phospholipid-bound choline concentrations, and choline administration attenuates endotoxin-induced organ injury in dogs. Shock 2005;24:288-293.
41. Treede I, Braun A, Sparla R, Kuhnel M, Giese T, Turner JR, Anes E, Kulaksiz H, Fullekrug J, Stremmel W, Griffiths G, Ehehalt R: Antiinflammatory effects of phosphatidylcholine. J Biol Chem 2007;282:27155-27164.
42. Ortega-Gutierrez S, Molina-Holgado E, Guaza C: Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia 2005;52:163-168.
43. Nakajima Y, Furuichi Y, Biswas KK, Hashiguchi T, Kawahara K, Yamaji K, Uchimura T, Izumi Y, Maruyama I: Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett 2006;580:613-619.
44. Chao W, Spragg RG, Smith RM: Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils: attenuation of p47phox and p67phox membrane translocation as the mechanism. J Clin Invest 1995;96:2654-2660.
45. Bendas G, Krause A, Schmidt R, Vogel J, Rothe U: Selectins as new targets for immunoliposome-mediated drug delivery: a potential way of anti-inflammatory therapy. Pharm Acta Helv 1998;73:19-26.
46. Sharpley MS, Shannon RJ, Draghi F, Hirst J: Interactions between phospholipids and NADH: ubiquinone oxidoreductase (complex I) from bovine mitochondria. Biochemistry 2006;45:241-248.
47. Bisaglia M, Venezia V, Biglieri M, Russo C, Mancini F, Milanese C, Schettini G: alpha-Glycerylphosphorylethanolamine rescues astrocytes from mitochondrial impairment and oxidative stress induced by amyloid beta-peptides. Neurochem Int 2004;44:161-170.
48. Karanian DA, Bahr BA: Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states. Curr Mol Med 2006;6:677-684.
49. Ashton JC: Cannabinoids for the treatment of inflammation. Curr Opin Invest Drugs 2007;8:373-384.
50. Berdyshev E, Boichot E, Corbel M, Germain N, Lagente V: Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci 1998;63:125-129.
51. D'Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, Di Marzo V: Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 2006;20:568-570.
52. Michalski CW, Laukert T, Sauliunaite D, Pacher P, Bergmann F, Agarwal N, Su Y, Giese T, Giese NA, Batkai S, Friess H, Kuner R: Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. Gastroenterology 2007;132:1968-1978.
53. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A: Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 1995;92:3376-3380.
54. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A: N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996;300:227-236.
55. Aloe L, Leon A, Levi-Montalcini R: A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 1993; 39(special No):C145-C147.
56. De Petrocellis L, Cascio MG, Di Marzo V: The endocannabinoid system: a general view and latest additions. Br J Pharmacol 2004;141:765-774.
57. Lambert DM, Vandevoorde S, Jonsson KO, Fowler CJ: The palmitoylethanolamide family: a new class of anti-inflammatory agents? Curr Med Chem 2002;9:663-674.
58. Horakova Z, Bayer BM, Almeida AP, Beaven MA: Evidence that histamine does not participate in carrageenan-induced pleurisy in rat. Eur J Pharmacol 1980;62:17-25.
59. Saito M, Shima C, Takagi M, Ogino M, Katori M, Majima M: Enhanced exudation of fibrinogen into the perivascular space in acute inflammation triggered by neutrophil migration. Inflamm Res 2002;51:324-331.
60. Grosman N: Comparison of the influence of NSAIDs with different COX-selectivity on histamine release from mast cells isolated from naïve and sensitized rats. Int Immunopharmacol 2007;7:532-540.